🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

6 Stocks That Could Pop Higher

Published 07/07/2020, 11:49 PM
Updated 07/09/2023, 06:31 AM

1. BioCryst

BioCryst Pharmaceuticals (NASDAQ:BCRX), in the biotech vaccine area, on Tuesday popped to 5.41, up 46 cents, or 9%, after reaching a midday high of 5.56, on 10.9 million shares traded. Strong volume pushed it to break out of a little wedge. Now, we have the objective of getting through 5.65, and making a run to the main spike-high at 6.29. if it gets through that, we’re looking at 7.00 as the next target.

2. Inovio Pharmaceuticals

Inovio Pharmaceuticals (NASDAQ:INO), another vaccine stock, popped on Tuesday to 24.09, up 3.16, or 15%, with a session high of 24.99, on 62 million shares traded. If momentum and the channel are correct, this stock is headed to 38 next.


MOGU (NYSE:MOGU), late in the day on Tuesday, exploded to 5.92, up 3.03, or 105%, after reaching all-time and session high highs at 6.85, on 22.4 million shares traded. It went from 2.61 to 6.85, a huge day for this stock, and a clean breakout, indeed. The next target is about 8.00.

4. Novavax

Novavax (NASDAQ:NVAX), yet another vaccine stock, the biggest and best I’ve seen all year, on Tuesday exploded 25.12, or 32%, to 104.56, with an all-time and session high of 111.77, on 26.3 million shares traded. Going from 4 to 111 is a fantastic move for a 6-month run. It seems to me that when this stock coiled and broke out, I said the way this stock looked, if it reached to the top of the channel it could be over 100. It reached 111.77 on a massive order from the government.

5. TG Therapeutics

TG Therapeutics (NASDAQ:TGTX) broke out on Tuesday and ran up 2.17, or 11%, to 22.52, with an all-time and session high of 22.78, on 3.2 million shares traded. TGTX, at this point, is running. My first target is 26.

6. Vaxart

Vaxart (NASDAQ:VXRT) was a monster on Tuesday, particularly late in the day. It ran up 2.43, or 38%, to 8.87, on 52.6 million shares traded, and then backed off in after-hours. It went from 7.50 to the session high at 8.98. Nevertheless, it had a strong pop a week and a half ago, then had a one-week long pull-back falling wedge, filled the gap and retested, and then popped. This pop is important. Above 9 3/4, and this looks like a 14-dollar stock again.

On the long side

Altimmune, Inc. (NASDAQ:ALT), BioCryst Pharmaceuticals, Inc. (BCRX), BiondVax Pharmaceuticals Ltd. (BVXV), CPS Technologies Corporation (CPSH), Cardiff Oncology, Inc. (CRDF), Cytokinetics, Incorporated (NASDAQ:CYTK), Arcimoto, Inc. (NASDAQ:FUV), Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), Inovio Pharmaceuticals, Inc. (INO), Livongo Health, Inc. (NASDAQ:LVGO), MOGU Inc. (MOGU), MTBC, Inc. (NASDAQ:MTBC), NIO Inc. (NIO), Niu Technologies (NASDAQ:NIU), Intellia Therapeutics, Inc. (NASDAQ:NTLA), Novavax, Inc. (NVAX), Overstock.com, Inc. (NASDAQ:OSTK), Origin Agritech Limited (SEED), TG Therapeutics, Inc. (TGTX), VBI Vaccines Inc. (NASDAQ:VBIV), and Vaxart (VXRT).

Watch video here...

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.